ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 2404
    RA Patients with Inadequate Response to Oral MTX Maintain Satisfactory Disease Control and Durable Long-Term Response When Switched to SC MTX Monotherapy
  • Abstract Number: 2290
    Race and Other Risk Markers of Uveitis in a Prospective Cohort of Children with Juvenile Idiopathic Arthritis
  • Abstract Number: 900
    Race and Sex Specific Incidence Rates and Predictors of Total Knee Arthroplasty: Data from the Osteoarthritis Initiative, 7 Years Follow up
  • Abstract Number: 1024
    Racial Differences in Biochemical Knee Cartilage Composition Between African American and Caucasian American Women with MR-Based T2 Relaxation Time Measurements – Data from the Osteoarthritis Initiative
  • Abstract Number: 1935
    Racial Disparities in Attitude Towards Treatment in Young Women
  • Abstract Number: 972
    Racial, Gender and Geographic Differences in Systemic Lupus Erythematous and Lupus Nephritis Mortality Rates in the Unites States, 1968-2010
  • Abstract Number: 1387
    Radiographic Progression Differs Between Trajectory Clusters Defined By DAS28 Scores in Early Rheumatoid Arthritis
  • Abstract Number: 595
    Radiographic Sacroiliitis Progression in an Early Axial Spondyloarthritis Cohort
  • Abstract Number: 2138
    Radiological Outcomes after Two Years of Remission Steered Treatment in Early Arthritis Patients
  • Abstract Number: 2262
    Raloxifene for Osteoporosis in Postmenopausal Women with Rheumatic Diseases
  • Abstract Number: L11
    Raman Spectroscopy: Point of Service Diagnosis Is Sensitive and Specific-a Tool for Improving Accuracy and Reducing Future Hospital Admission
  • Abstract Number: 2860
    Randomised Comparison of the Effectiveness of a Non-Pharmacological Multidisciplinary Face-to-Face Group-Based Treatment Program Vs. a Telephone-Delivered Treatment Program on Daily Function in Patients with Generalized Osteoarthritis
  • Abstract Number: 1843
    Randomised Controlled Non-Inferiority Study of Dose Reduction and Withdrawal of Adalimumab and Etanercept in Rheumatoid Arthritis
  • Abstract Number: 977
    Randomized Clinical Trial of a Patient and Provider Intervention for Managing Osteoarthritis in Veterans
  • Abstract Number: 891
    Randomized Clinical Trial of Group Vs. Individual Physical Therapy for Knee Osteoarthritis
  • Abstract Number: 2859
    Randomized Controlled Trial of Postoperative Care Navigation in Total Knee Arthroplasty Patients: Does One Size Fit All?
  • Abstract Number: 920
    Randomized Controlled Trial to Assess the Safety and Efficacy of Odanacatib in the Treatment of Men with Osteoporosis
  • Abstract Number: L19
    Randomized Trial of Stopping TNF-Inhibitors in Rheumatoid Arthritis Patients with Stable Low Disease Activity in the Netherlands
  • Abstract Number: 238
    RANKL and OPG Gene Polymorphisms: Association with Vertebral Fractures and Bone Mineral Density in Premenopausal Systemic Lupus Erythematosus
  • Abstract Number: 2722
    Rapamycin Corrects GATA-3 Deficiency in Lupus Treg
  • Abstract Number: 1486
    Rapid Onset of Clinical Benefit Is Associated with a Reduction in Validated Biomarkers of Disease in Patients with Rheumatoid Arthritis Treated with Mavrilimumab, a Human Monoclonal Antibody Targeting GM-CSFRá
  • Abstract Number: 1656
    Rate of Histological Transformation to Higher Grade  Nephritis in Class II Mesangial Proliferative Lupus Glomerulonephritis
  • Abstract Number: 901
    Rate of Serum Uric Acid (SUA) Assessment in Gout Patients Treated with Urate-Lowering Therapy: Treating to Target?
  • Abstract Number: 1051
    Rates of Renal Remission with Immunosuppressives in Lupus Nephritis: A Systematic Review and Network Meta-Analysis
  • Abstract Number: 2010
    Reaching out to Physical Therapists:  Results of a Survey on Physical Therapists Preferences for Learning about Evidence-Based Community Programs
  • Abstract Number: 484
    Reactivation of Hepatitis B Virus in Patients with Rheumatoid Arthritis after Anti-TNF Therapy
  • Abstract Number: 2121
    Real-World Cost Comparison of Urate Lowering Therapies in Patients with Gout and Moderate to Severe Chronic Kidney Disease
  • Abstract Number: 517
    Real-World Use of Tocilizumab in Rheumatoid Arthritis Patients in Canada: Interim Results
  • Abstract Number: 102
    Real-World Utilization, Patient Characteristics and Persistency of Certolizumab Pegol Vs Other Anti-TNFs for the Treatment of Rheumatoid Arthritis in the United Kingdom
  • Abstract Number: 956
    Real-World Validation of the Minimal Disease Activity Index in Psoriatic Arthritis: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada
  • Abstract Number: 2516
    Reasons and Risk Factor for Discontinuation of Biologic Agents in Rheumatoid Arthritis Patients
  • Abstract Number: 104
    Reasons for Leaving an Academic Career in Research Among Rheumatologists in the United States
  • Abstract Number: 2385
    Reasons for Non-Vaccination in Rheumatoid Arthritis and Spondyloarthritis Patients
  • Abstract Number: 2572
    Recognition of  Spondyloarthritis By General Practitioners in Daily Practice and the Effect of Education on This; A Study with Standardized Patients
  • Abstract Number: 1235
    Recovery of Renal Function after Corticosteroid Therapy for IgG4-Related Kidney Disease
  • Abstract Number: 1417
    Red Cell Distribution Width: A Measure for Cardiovascular Risk in Rheumatoid Arthritis Patients?
  • Abstract Number: 2210
    Redefining Dermatomyositis: Description of New Diagnostic Criteria That Differentiate Pure Dermatomyositis from Overlap Myositis with Dermatomyositis Features
  • Abstract Number: 2342
    Redox Regulation of a New Autoimmune Mouse Model, Glucose-6-Phosphate Isomerase Peptide Induced Arthritis in Mice
  • Abstract Number: 725
    Reduced Diffusing Capacity of Carbon Monoxide Is Independently Associated with Worse Subclinical Left Ventricular Function on Speckle-Tracking Echocardiography in Systemic Sclerosis
  • Abstract Number: 241
    Reduced Estimated Glomerular Filtration Rate Was Improved after Cessation of NSAID and Switching to Tramadol Hydrochloride/Acetaminophen Tablets (UltracetTM) in Patients with Chronic Musculoskeletal Pain
  • Abstract Number: 1016
    Reduced Expression of Circadian Rhythm Genes in Human Osteoarthritis Cartilage: NR1D1 Suppression Alters Chondrocyte Response to IL-1β Stimulation
  • Abstract Number: 2753
    Reduced Heart Rate Variability in Patients with Behcet’s Disease
  • Abstract Number: 344
    Reduced Macrophages in the Synovium Contribute to the Effective Treatment of Spontanneous Arthritis Observeded in Human TNF-Transgenic Mice
  • Abstract Number: 2810
    Reduced Mortality Risk in Rheumatoid Arthritis: Findings from Two UK Inception Cohorts
  • Abstract Number: 940
    Reducing Therapy in Rheumatoid Arthritis Patients in Ongoing Remission
  • Abstract Number: 963
    Reduction in Proteinuria and Normalization of C4 Complement Levels Predict Response to Treatment of Lupus Nephritis with Low-Dose Pulse Cyclophosphamide and Abatacept
  • Abstract Number: 2705
    Reduction of Cerebral and Corpus Callosum Volume in Systemic Sclerosis. a Volumetric Magnetic Resonance Imaging Study
  • Abstract Number: 2246
    Reduction of Knee Osteoarthritis Symptoms in a Cohort of Bariatric Surgery Patients
  • Abstract Number: 2728
    Reduction of MAIT Cell Frequency Associated with Reduced Cell Proliferation and Enhanced Cell Death in Systemic Lupus Erythematosus
  • Abstract Number: 2221
    Reduction of Ovarian Reserve in Adult Patients with Dermatomyositis
  • Abstract Number: 1009
    Regeneration of Articular Cartilage in Situ with Bone Marrow-Derived Mesenchymal Stem Cells
  • Abstract Number: 2412
    Regime of Use of Rituximab in Patients with Rheumatoid Arthritis in Daily Clinical Practice
  • Abstract Number: 1675
    Regional Implantation of Adipose Tissue-Derived Cells Induces a Prompt Healing of Long-Lasting Indolent Digital Ulcers in Patients with Systemic Sclerosis
  • Abstract Number: 37
    Regulation of Osteoclast and T Cell Differentiation By DC-STAMP and TRAF3
  • Abstract Number: 1128
    Regulation of PIWIL4 By Histone Modifications in Rheumatoid Arthritis
  • Abstract Number: 32
    Regulation of Senescence and Inflammatory Mediators By N- and C-Terminal Parathyroid Hormone-Related Protein in Osteoarthritic Human Osteoblasts  
  • Abstract Number: 1942
    Regulation of the Responses of Human B Cell Subsets to Innate Immune Signals By Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22
  • Abstract Number: 324
    Regulation of TNF-α-Mediated Activation of Rheumatoid Synovial Fibroblasts By Transcription Factor Snail
  • Abstract Number: 835
    Relapsing Polychondritis Can be Characterized By 3 Different Clinical Phenotypes: Analysis of a Series of 142 Patients
  • Abstract Number: 2387
    Relation Between Disease Activity Indices and Their Individual Components and Radiographic Progression in Rheumatoid Arthritis: A Systematic Literature Review
  • Abstract Number: 1539
    Relation Between Number of Previous Anti TNF Agents and Clinical Response in Rheumatoid Arthritis Patients Treated with Rituximab
  • Abstract Number: 973
    Relation of Pelvic Drop during Walking to Risk of Incident Medial Knee Osteoarthritis: The Multicenter Osteoarthritis Study
  • Abstract Number: 212
    Relation of Shoe Stability to Risk of Knee Cartilage Damage: The Multicenter Osteoarthritis Study
  • Abstract Number: 1647
    Relationship Between Apom/S1P Levels and Atherosclerosis in Women with Systemic Lupus Erythematosus
  • Abstract Number: 2488
    Relationship Between Different Clinical Measurements and Patient-Reported Outcomes
  • Abstract Number: 508
    Relationship Between NK Cell Count and Important Safety Events in Rheumatoid Arthritis Patients Treated with Tofacitinib
  • Abstract Number: 1570
    Relationship Between Psoriatic Arthritis Severity, Duration, and Comorbidities
  • Abstract Number: 414
    Relationship Between Range of Motion of Joints in Upper Limbs and Physical Function in Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function
  • Abstract Number: 112
    Relationship Between Rheumatology Physician Supply and Travel Distances to Rheumatologists for Medicare Beneficiaries in the United States
  • Abstract Number: 2696
    Relationship Between Soluble sCD23 and B Cell Activation Factor in Patients with Systemic Lupus Erythematosus before and after Rituximab
  • Abstract Number: 2149
    Relationship Between the Magnitude of Bone Formation in the Anterior Vertebral Corners, As Assessed through 18F-Fluoride Uptake, and Lumbar Spine Bone Mineral Density in Patients with Ankylosing Spondylitis
  • Abstract Number: 1280
    Relationship of Buckling and Knee Injury to Pain Exacerbation in Knee Osteoarthritis: A Web-Based Case-Crossover Stud
  • Abstract Number: 2894
    Relationship of Dermal Advanced Glycation End Products and Hand OA
  • Abstract Number: 2626
    Relationship of Socio-Demographic and Disease Factors with Loss-to-Follow-up and Appointment Noncompliance in Indigent Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1291
    Relationships Between Inflammation, Disease Severity and Synovial Fluid Calcium Crystals Detected By Scanning Electronic Microscopy in Early Osteoarthritis
  • Abstract Number: 2183
    Release of Enzymatically Active Peptidyl Arginine Deiminases (PADs) By Neutrophils Allows Generation of Citrullinated Extracellular Autoantigens in the Synovial Fluid of Patients with Rheumatoid Arthritis
  • Abstract Number: 2701
    Relevance of the 6-Minute Walking Test in Assessing the Severity and Outcome of Pulmonary Arterial Hypertension Associated with Systemic Sclerosis, without Extensive Interstitial Lung Disease
  • Abstract Number: 549
    Reliability and Construct Validity of the Psoriasis Symptom Inventory in Subjects with Psoriatic Arthritis
  • Abstract Number: 2335
    Reliability and Validity of the Arthritis Helplessness Index in Systemic Sclerosis
  • Abstract Number: 2715
    Reliability and Validity of the Duruöz Hand Index in an Argentinian Population with Scleroderma
  • Abstract Number: 2614
    Reliability of Electronic Patient Self-Assessment of Swollen and Tender Joints in Psoriatic Arthritis: A Comparison Study with B-Mode Ultrasonography, Physician and Nurse Assessments
  • Abstract Number: 737
    Reliability of Nailfold Capillary Density Measurement As a Possible Outcome Measure for Systemic Sclerosis-Related Microangiopathy
  • Abstract Number: 352
    Remaining Pain in Spite of Suppressed Inflammation in Early Rheumatoid Arthritis – Long-Term Strongly Increased Risk for Widespread Pain and Fatigue
  • Abstract Number: L15
    Remission Induction By Etanercept in Enthesitis Related Arthritis JIA-Patients (juvenile undifferentiated Spondylarthropathy)
  • Abstract Number: 474
    Renacer Study: Assessment of 12-Month Efficacy and Safety of 168 Certolizumabpegol Rheumatoid Arthritis Treated Patients from a Multicenter Retrospective National Study in Spain
  • Abstract Number: 2549
    Renal Involvement in Primary Sjögren’s Syndrome: A Multicenter French Study of 95 Biopsy Proven Cases
  • Abstract Number: 1671
    Renal Relapses Are Common in Lupus Nephritis
  • Abstract Number: 1658
    Renal Thrombotic Microangiopathy in Systemic Lupus Erythematosus: Novel Risk Factors and Clinical Outcomes
  • Abstract Number: 2086
    Replication of PTPRC As Genetic Biomarker of Response to TNF Inhibitors in Patients with Rheumatoid Arthritis
  • Abstract Number: 1188
    Reproducibility of Magnetic Resonance Imaging Diffusion Weighted Imaging in Axial Spondyloarthritis Patients and Healthy Subjects
  • Abstract Number: 1992
    Resident’s Guide to Rheumatology Mobile Application: An International Needs Assessment
  • Abstract Number: 2975
    Residual Large Joint Synovitis By Power Doppler Ultrasonography Is Associated with Higher Disease Activity and Significant Impact of Disease in Multi-Ethnic Asian Patients with Established Rheumatoid Arthritis
  • Abstract Number: 1588
    Resistance Training in Patients with Psoriatic Arthritis Improves Function, Disease Activity and Quality of Life
  • Abstract Number: 105
    Resource Use and Health Related Quality of Life Burden of Gout Exacerbated By Common Comorbidities: Results from the 2012-2013 National Health and Wellness Survey
  • Abstract Number: 2038
    Respiratory Cause Mortality Was Significantly Predicted By Incident Rheumatoid Arthritis (RA) and Higher Pre-RA Levels (0.50+ SD) of Soluble Interleukin-2 Receptor Alpha (sIL-2Rá): Results of a 21-Year Community-Based Cohort Survival Analysis
  • Abstract Number: 1482
    Response of Patient Reported Symptoms of Stiffness and Pain during the Day from Adding Low-Dose Delayed-Release (DR) Prednisone to Stable DMARD Therapy over 12 Weeks in Patients with Moderate Rheumatoid Arthritis (RA)
  • Abstract Number: 931
    Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients
  • Abstract Number: 676
    Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register
  • Abstract Number: 897
    Resting State Functional Connectivity Differs Between Chronic Fatigue Syndrome Patients and Healthy Controls
  • Abstract Number: 2857
    Restricting Back Pain Is Strongly Associated with Disability in Community-Living Older Persons over the Course of 13 Years
  • Abstract Number: 1277
    Retinal Arteriolar Narrowing and Incidence of Knee Replacement for Osteoarthritis: A Prospective Cohort Study
  • Abstract Number: 1237
    Retroperitoneal Fibrosis and IgG4 Disease: Response to Immunosuppressive Therapy – a Single Centre Retrospective Study
  • Abstract Number: 281
    Retrospective Review of Immobilization Vs. Immediate Resumption of Activity in Patients with Oligoarticular Juvenile Idiopathic Arthritis and Corticosteroid Knee Injections
  • Abstract Number: 1576
    Reversal of Damage in Psoriatic Arthritis
  • Abstract Number: 187
    Revision Arthroplasty in Rheumatoid and Osteoarthritis: Does Methotrexate Decrease Radiographic Lucency in RA Patients?
  • Abstract Number: 2187
    Revisiting RS3PE after Twenty Five Years: A Systematic Review of 250 Cases
  • Abstract Number: 1352
    Rheumatoid Arthritis (RA) Disease Activity Assessment and Population Management Processes Used By Clinician Rheumatologists
  • Abstract Number: 1889
    Rheumatoid Arthritis (RA)-Associated Risk Allele LBH Alters the Function of a Differentially Methylated LBH Enhancer
  • Abstract Number: 2136
    Rheumatoid Arthritis Erosion Detection and Measurement in Longitudinal Datasets Using High-Resolution Peripheral Quantitative Computed Tomography
  • Abstract Number: 995
    Rheumatoid Arthritis Patients Have Alterations in Inherently Autoreactive 9G4+ B-Cell Subpopulations in Peripheral Blood
  • Abstract Number: 2425
    Rheumatoid Arthritis Stable Follow up Visits – 3 Month Versus 6 Month Intervals
  • Abstract Number: 432
    Rheumatoid Arthritis-Associated Interstitial Lung Disease: Risk Factors for Disease Progression
  • Abstract Number: 846
    Rheumatoid Arthritis, Anti-Tumor Necrosis Factor Therapy, and Risk of Squamous Cell and Basal Cell Skin Cancer- a Nationwide Population Based Prospective Cohort Study from Sweden
  • Abstract Number: 1904
    Rheumatoid Factor Isotype Testing to Identify Individuals in the Preclinical Period of Rheumatoid Arthritis
  • Abstract Number: 447
    Rheumatoid Factor Isotypes in Relation to Antibodies Against Citrullinated Peptides in Individuals before Onset of Rheumatoid Arthritis
  • Abstract Number: 1560
    Rheumatoid Factor Status Is a Predictor of Osteoporosis in Patients with Psoriatic Arthritis
  • Abstract Number: 1054
    Rheumatoid Factor, Not ACPA, Is Associated with Disease Activity in Rheumatoid Arthritis
  • Abstract Number: 1361
    Rheumatologists’ Attitudes on Cardiovascular Risk and Lipid Screening in Patients with Rheumatoid Arthritis at an Academic Medical Center
  • Abstract Number: 103
    Rheumatology e-Consult Services:  a Rheumatology Workforce Management Model
  • Abstract Number: 1985
    Rheumatology Learning Management System
  • Abstract Number: 2883
    Rheumatology-Specific Milestones for a Musculoskeletal Radiology Curriculum
  • Abstract Number: 781
    Rho Kinase (ROCK) Activity in Aortitis: Comparison of Giant Cell Arteritis (GCA), Takayasu Arteritis (TA) and Isolated Aortitis (IA)
  • Abstract Number: 350
    Rho-Associated Protein Kinase (ROCK) Activity Is Elevated in Rheumatoid Arthritis (RA) Patients and May be Responsive to RA Therapies
  • Abstract Number: 740
    Right Ventricular Diastolic Impairment Is Common in Systemic Sclerosis and Is a Marker of Several Organ-Target Damage of the Disease
  • Abstract Number: 475
    Risk Analysis of a First Adverse Event and Recurrent Infections during Biological Therapy in Chronic Inflammatory Arthritis
  • Abstract Number: 862
    Risk Factors for Changes in Subclinical Atherosclerosis As Measured By Carotid Intima Media Thickness (IMT) and Plaque over 5 Years in Women with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 223
    Risk Factors for Clinical Vertebral Fractures in Japanese Men and Women with Rheumatoid Arthritis: Results from a Large Prospective Observational Cohort Study
  • Abstract Number: 166
    Risk Factors for Gout Attack Recurrence during Urate-Lowering Allopurinol Treatment
  • Abstract Number: 206
    Risk Factors for Increased Extrusion of the Meniscus Body in Subjects Free of Radiographic Knee Osteoarthritis: 6-Year MRI Data from the Osteoarthritis Initiative
  • Abstract Number: 2990
    Risk Factors for Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus Patients: A Single Center Study
  • Abstract Number: 236
    Risk Factors for Prevalent and Progressive Bone Deficits Among Adult Men and Women with Cystic Fibrosis
  • Abstract Number: 809
    Risk Factors for Severe Ischemic Complications in Takayasu Arteritis: A French Multicenter Retrospective Cohort of 182 Patients
  • Abstract Number: 2266
    Risk Factors for Treatment Failure in Osteoporotic Patients with Rheumatoid Arthritis
  • Abstract Number: 230
    Risk Factors That Predict Poor Bone Health in Those Aged over 75 Years – a Cross Sectional Study
  • Abstract Number: 2154
    Risk for Developing Adult T-Cell Leukemia in Patients with Human T Lymphotropic Virus Type-I Carrier Receiving Immunosuppressive Therapy
  • Abstract Number: 823
    Risk of Active Tuberculosis in Patients with Arthritis Receiving TNF-α Inhibitors: A Look Beyond the Baseline Tuberculosis Screening Protocol
  • Abstract Number: 1848
    Risk of Cancer in Patients with Severe Psoriatic Arthritis Requiring Tumour-Necrosis Factor Alpha Inhibition
  • Abstract Number: 2628
    Risk of Cancer Is Not Increased in Patients with Cutaneous Lupus Erythematosus: A Population-Based Study
  • Abstract Number: 2642
    Risk of Cardiovascular Events in Patients with Cutaneous Lupus Erythematosus: A Population-Based Study
  • Abstract Number: 2545
    Risk of Cervical Root and Incisal Caries in Patients with Sjogren’s Syndrome
  • Abstract Number: 970
    Risk of Developing Antiphospholipid Syndrome Following Infection: A Systematic Review and Meta-Analysis of Observational Studies
  • Abstract Number: 483
    Risk of HBV Reactivation in Rheumatoid Arthritis Patients Undergoing Treatment with Newer Biological Dmards, Tocilizumab and Abatacept: A Single-Center Real Life Experience
  • Abstract Number: 1075
    Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with Systemic Lupus Erythematosus on Immunosuppressive Drugs
  • Abstract Number: 57
    Risk of Hospitalized Infection in a Psoriasis/Psoriatic Arthritis Cohort
  • Abstract Number: 2665
    Risk of Hydrocephalus and/or Macrocephaly in Children Born to Mothers with SLE
  • Abstract Number: 1910
    Risk of Hypersensitiviy Among Medicare Patients with Rheumatoid Arthritis Who Were Taking Biologics
  • Abstract Number: 518
    Risk of Infection Associated with Subsequent Biologic Use Following Rituximab—Results from a National RA Patient Registry
  • Abstract Number: 1082
    Risk of Intra Cranial Hemorrhage among Patients with Anti-Phospho-Lipid-Antibody (aPL) syndrome vs Systemic Lupus Erythematosus (SLE) in Stroke Population: A Nationwide Analysis
  • Abstract Number: 726
    Risk of Ischemic Stroke in Patients with Systemic Sclerosis: A Systematic Review and Meta-Analysis
  • Abstract Number: 1849
    Risk of Malignancy Among Medicare Psoriasis/Psoriasis Arthritis Patients
  • Abstract Number: 1546
    Risk of Non Melanoma Skin Cancer Among Medicare Psoriasis/Psoriasis Arthritis Patients
  • Abstract Number: 1589
    Risk of Opportunistic Infection and Herpes Zoster Infection in a Psoriasis/Psoriatic Arthritis Cohort
  • Abstract Number: 1839
    Risk of Recurrent Non-Melanoma Skin Cancer with Methotrexate and Anti-TNF Use in Rheumatoid Arthritis
  • Abstract Number: 1400
    Risk of Venous Thromboembolic Events in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
  • Abstract Number: 2531
    Risk of Venous Thromboembolism in Patients with Sjogren’s Syndrome: A Systematic Review and Meta-Analysis
  • Abstract Number: 1524
    Rituximab Done! What’s Next in RA?
  • Abstract Number: 2804
    Rituximab in IgG4-Related Disease: A Large Single-Center Experience
  • Abstract Number: 1419
    Rituximab Use in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease and Other Connective Tissue Disease-Associated Interstitial Lung Disease: A Single Center Experience
  • Abstract Number: 1778
    Rituximab Versus Azathioprine for ANCA-Associated Vasculitis Maintenance Therapy: Impact in Health-Related Quality of Life
  • Abstract Number: 14
    Rivaroxaban Use in Patients with Antiphospholipid Syndrome Patients and Previous Poor Anticoagulation Control with Vitamin K Antagonists
  • Abstract Number: 1814
    RNA-Containing Immune Complexes Shift Human Neutrophils from Phagocytosing Cells to Efficient Releasers of Oxidized DNA in a Process Requiring Crosstalk Between Toll-like Receptors and Fc Gamma Receptor IIa
  • Abstract Number: 772
    RNA-Seq and Mir-Seq Analysis of SSc Skin Across Intrinsic Gene Expression Subsets Shows Differential Expression of Non-Coding RNAs Regulating SSc Gene Expression
  • Abstract Number: 75
    Robust Identification of Anti-TNF Non-Responders in RA from Blood
  • Abstract Number: 340
    Role of Beta-Catenin Signaling to Control Dendritic Cell Function in Collagen-Induced Arthritis
  • Abstract Number: 1829
    Role of Fluorinated Steroids in Preventing the Progression of Anti-SSA/Ro Associated Isolated Congenital Heart Block to Disease Beyond the Conduction System
  • Abstract Number: 1012
    Role of High Glucose Environment on Chondrocyte Activation and Characterization of Diabetic Osteoarthritic Cartilage: Toward Pathophysiological Delineation of Diabetes Mellitus-Related Osteoarthritis
  • Abstract Number: 1808
    Role of HLA-B*5801 Genetic Testing and a Safety Programme When Initiating Allopurinol Therapy for Chronic Gout Management: A Cost-Effectiveness Analysis
  • Abstract Number: 1643
    Role of Inflammasome Activation in Systemic Lupus Erthematosus: Are Innate Immune Cells Activated?
  • Abstract Number: 287
    Role of Joint Status in Decreased Accelerometer-Assessed Daily Physical Activity in Juvenile Idiopathic Arthritis
  • Abstract Number: 1978
    Role of Monocytes Subsets in the Pathology of Rheumatoid Arthritis: Involvement in Endothelial Dysfunction and Proinflammatory Profile
  • Abstract Number: 2173
    Role of Natural Killer Cells and Gamma Delta T Cells in Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis
  • Abstract Number: 1134
    Role of NOD2 Pathway in Sarcoidosis Cases with Characteristics of Blau Syndrome
  • Abstract Number: 2352
    RORγt Expressing Foxp3+ Regulatory T Cells Regulates the Development of Autoimmune Arthritis in Mice
  • Abstract Number: 489
    Rosuvastatin Improves Arterial Stiffness in Patients with Inflammatory Joint Diseases
  • Abstract Number: 1913
    Rosuvastatin Induced Carotid Plaque Regression in Patients with Inflammatory Joint Diseases
  • Abstract Number: 2568
    Routine Assessment of Patient Index Data (RAPID3) Provides Similar Information Compared to Ankylosing Spondylitis Specific Indices: Analyses of the DESIR French Cohort
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.